Samantha S. Davis

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease”.

Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease

Frontiers in Genetics(2023)10.3389/fgene.2023.1118649

N/A

0.589DataRank · unranked

20 citations

Jon J. Brudvig, Shibi Likhite, Melissa A. Pratt, Katherine A. White, Jacob T. Cain +10 more

AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease

Molecular Therapy(2020)10.1016/j.ymthe.2020.09.033

N/A

0DataRank · unranked

43 citations

Katherine A. White, Jon J. Brudvig, Jacob T. Cain, Logan M. Langin, Melissa A. Pratt +8 more

AAV9 gene therapy restores lifespan and treats pathological and behavioral abnormalities in a mouse model of CLN8-Batten disease

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.05.079350

N/A

0DataRank · unranked

1 citations

Katherine A. White, Jacob T. Cain, Logan M. Langin, Melissa A. Pratt, Jon J. Brudvig +8 more

Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease mice

Molecular Therapy — Methods & Clinical Development(2021)10.1016/j.omtm.2020.12.014

N/A

0DataRank · unranked

19 citations

Hemanth R. Nelvagal, Timothy A. Poole, Bin Lü, Tyler B. Johnson, Samantha S. Davis +10 more